| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ALUMIS INC. | Chief Medical Officer | Common Stock | 28,450 | $100,144 | $3.52 | 29 Jul 2025 | Direct |
| ALUMIS INC. | Chief Medical Officer | Stock Option (Right to Buy) | 221,450 | 26 Jan 2026 | Direct | ||
| Ventyx Biosciences, Inc. | Chief Medical Officer | Stock Option (right to buy) | 145,000 | 04 Feb 2022 | Direct | ||
| ALPINE IMMUNE SCIENCES, INC. | Director | Stock Option (Right to buy) | 0 | 20 May 2024 | Direct |